Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor. 1979

M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc

This report describes a patient without evident underlying disease, in whom an acquired von Willebrand's syndrome was discovered before surgery. Coagulation abnormalities included a borderline bleeding time, a low retention of platelets on glass beads, decreased levels of factor VIII procoagulant activity (VIIIAHF), factor VIII-related antigen (VIIIAg), and ristocetin-induced agglutination cofactor (VIIIVWF). After cryoprecipitate infusion the patient did not have the expected rise and there was no secondary increment in VIIIAHF. The patient was treated with prednisone for three weeks without significant improvement in the laboratory findings. Spontaneous resolution was observed long after this therapy. The haemostatic abnormalities were attributable to the presence of an inhibitor directed against VIIIVWF. The inhibitor was found in the IgM fraction. Its autoimmune nature is probable although we failed to demonstrate any inhibitory effect of Fab obtained from the patient's purified IgM. Despite the lack of inhibitory effect against VIIIAHF and VIIIAg, the low levels of all three activities of the factor VIII complex could be explained by the short half-life of immune complexes between factor VIII and the inhibitor.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
May 1980, British journal of haematology,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
January 1987, Acta haematologica,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
January 1989, The American journal of pediatric hematology/oncology,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
September 1979, Schweizerische medizinische Wochenschrift,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
February 1980, Thrombosis and haemostasis,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
August 1971, British journal of haematology,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
November 1980, British journal of haematology,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
January 1998, Irish journal of medical science,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
May 1993, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Gouault-Heilmann, and M D Dumont, and L Intrator, and C Chenal, and J L Lejonc
December 1992, Hematology/oncology clinics of North America,
Copied contents to your clipboard!